Back

Safety and efficacy of first in-human use of muscle-derived stem cells transfected with connexin-43 gene for chronic heart failure

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Basic Science: Gene and cell therapy Gene and cell therapy HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Ewa Straburzynska-Migaj

Poznan University of Medical Sciences, Poznan (Poland)

11 More presentations in this session

Presentation thumbnail
HFWM: C-kit+ resident cardiac stem cells improve left ventricular fibrosis in pressure overload
Doctor A. Kazakov (Homburg, DE)
Abstract Slides
Presentation thumbnail
HFWM: An in vivo selection strategy for the identification of novel cytokines inducing cardiac retention of murine mesenchymal stromal cells after myocardial infarction
Miss F. Bortolotti (Trieste, IT)
Abstract
Presentation thumbnail
HFWM: The H19 long non-coding RNA regulates pathological cardiac hypertrophy
Presentation thumbnail
Safety and efficacy of transendocardial injection of induced-pluripotent stem cells-derived mesenchymal cells in a swine subacute model of myocardial ischemia.
Doctor A. Climent (Valencia, ES)
Abstract Slides
Presentation thumbnail
A combined cellular and surgical ventricular reconstruction therapeutic approach produces attenuation of remodeling in infarcted rats
Doctor C. Kapelios (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Basic Science: Gene and cell therapy

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources